Nerve growth factor expression and function in pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Circulating angiopoietins in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010
Elevated pulmonary capillary pressure in pulmonary arterial hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 3s Year: 2001
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Macrophage migration inhibitory factor (MIF ) promoter polymorphisms are associated with favorable hemodynamic indices in systemic sclerosis-associated pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012
Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006
The pulmonary artery pulsatility index correlates with ventriculo-vascular coupling and elevated filling pressures in patients with pulmonary arterial hypertension. Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018
Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018 Year: 2018
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease Source: Eur Respir J 2013; 41: 217-223 Year: 2013
Elevated pulmonary artery to aortic ratio measured with MRI identifies patients with pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 312s Year: 2005
Peripheral endothelial dysfunction in patients with pulmonary artery hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007
Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH) Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012